To address this issue, we investigated the in vitro cytotoxicity of Tra-Exa-PSAR10 in HER2+ breast (MDA-MB-361) and esophageal (OE-19) cancer cell lines that were rendered resistant to T-DM1. This evidence concerns the gene ERBB2 and cancer.